← FDA Drug Approvals (Drugs@FDA)

VALSARTAN AND HYDROCHLOROTHIAZIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2026-04-23

Drug application

FDA Application #

ANDA204687

Application type

Abbreviated New Drug Application (Generic)

Brand name

VALSARTAN AND HYDROCHLOROTHIAZIDE

Generic name

Hydrochlorothiazide

Active ingredients

HYDROCHLOROTHIAZIDE; VALSARTAN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

SCIEGEN PHARMS

First approval

2026-04-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown